The outlook revision is based on a number of financial and strategic challenges, including an operating loss related to Geisinger’s health plan’s exchange product.
Moody’s Investors Service also affirmed the “Aa2” and “Aa2/VMIG 1” ratings on Geisinger’s outstanding bonds. The rating affirmations are based on Geisinger’s large size, leading market position and exceptional clinical reputation.
More articles on healthcare finance:
Surprise billing legislation stalls again on East Coast
For-profit hospital stock report: Week of Nov. 21-25
Medicare cancer patients without additional coverage hit with high out-of-pocket costs: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
